Similar to Hemopure, Oxyglobin is also developed by OPK Biotech LLC and is an oxygen-therapeutic based on chemically stabilized bovine hemoglobin. However, unlike Hemopure, which is for human use, Oxyglobin is intended for the veterinary market, and is used to treat anemia in dogs. According to OPK Biotech's corporate website, approximately 173,000 units of Oxyglobin have been sold to date, treating nearly 90,000 animals.
Use in Other Animals
In 2014, staff members at the Wildlife Aid Foundation used Oxyglobin to treat a young female badger which was suffering from anemia so severely that "We didn't know how she was even still alive." They did not have ability to give the animal the necessary blood transfusion so this was their only alternative. Amazingly it worked and the animal fully recovered. It was to their knowledge the first time Oxyglobin had been used on a badger.